Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Ghai Jyotsna
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Spaventa Andrew
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Meeter Dalen
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Glezer Eli N.
Singular Genomics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CRCM Institutional Master Fund (BVI), Ltd.(4.61%),CRCM LP(4.61%), etc.
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Spaventa Andrew
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Ghai Jyotsna
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Glezer Eli N.
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Meeter Dalen
Singular Genomics | SC 13D: Statement of acquisition of beneficial ownership by individuals-CRCM Institutional Master Fund (BVI), Ltd.(5.6%),CRCM LP(5.6%), etc.
Singular Genomics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Mgmt IV, L.P.(6.66%),Deerfield Private Design Fund IV, L.P.(6.66%), etc.
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Ghai Jyotsna
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-10% Owner TANG KEVIN
Singular Genomics | 3: Initial statement of beneficial ownership of securities-10% Owner TANG KEVIN
Singular Genomics | SC 13D: Statement of acquisition of beneficial ownership by individuals-TANG CAPITAL MANAGEMENT, LLC(14.9%),KEVIN TANG(14.9%), etc.
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Meeter Dalen
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Glezer Eli N.
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Spaventa Andrew
Singular Genomics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Deerfield Mgmt IV, L.P.(6.66%),Deerfield Private Design Fund IV, L.P.(6.66%), etc.
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Spaventa Andrew
Unlock the Full List